|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
intramuscular injection
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:MenQuadfi
gptkb:Menveo
gptkb:Menactra
|
|
gptkbp:broadcastOn
|
booster dose at 16 years
first dose at 11-12 years
|
|
gptkbp:contains
|
polysaccharide antigens
diphtheria toxoid protein carrier
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
severe allergic reaction to vaccine component
|
|
gptkbp:fullName
|
Meningococcal Conjugate Vaccine, Quadrivalent
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MCV-4
|
|
gptkbp:introduced
|
2005
|
|
gptkbp:notEffectiveAgainst
|
Neisseria meningitidis serogroup B
|
|
gptkbp:prevention
|
meningitis
septicemia
meningococcal disease
|
|
gptkbp:protectedBy
|
gptkb:Neisseria_meningitidis_serogroup_A
gptkb:Neisseria_meningitidis_serogroup_C
gptkb:Neisseria_meningitidis_serogroup_Y
Neisseria meningitidis serogroup W
|
|
gptkbp:recommendation
|
gptkb:CDC
gptkb:ACIP
adolescents
college students
military recruits
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
pain at injection site
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:type
|
vaccine
|
|
gptkbp:usedIn
|
gptkb:Australia
gptkb:Canada
gptkb:Europe
gptkb:United_States
|
|
gptkbp:WHOPrequalified
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Molluscum_contagiosum_virus
|
|
gptkbp:bfsLayer
|
6
|